论文部分内容阅读
目的:探讨阿奇霉素联合羧甲司坦治疗急性气管-支气管炎的疗效。方法:选自2016年6月-2017年6月本院收治的急性气管-支气管炎患者78例临床资料,设分对照组和观察组,各39例,对照组使用阿奇霉素治疗,观察组使用阿奇霉素联合羧甲司坦治疗,对比两组临床症状及治疗后生活质量。结果:观察组临床症状咳嗽(8.34±2.73)分、发热(4.36±3.52)分、肺部啰音(8.35±4.56)、咽部疼痛(8.56±2.47)分比较均优于对照组,比较差异均具有统计学意义(P<0.05);观察组生活质量评分优于对照组,比较差异具有统计学意义(P<0.05)。结论:治疗急性气管-支气管炎使用阿奇霉素联合羧甲司坦的疗效能够有效缓解病情,副作用小、安全性高,可在临床上推广使用。
Objective: To investigate the curative effect of azithromycin and carbocisteine in the treatment of acute tracheobronchitis. Methods: From June 2016 to June 2017, 78 patients with acute tracheobronchitis in our hospital were divided into control group and observation group, 39 cases in each group. The control group was treated with azithromycin. The observation group was treated with azithromycin In combination with carbetol’s treatment, the clinical symptoms and the quality of life after treatment were compared. Results: The cough (8.34 ± 2.73), fever (4.36 ± 3.52), pulmonary rales (8.35 ± 4.56) and pharyngeal pain (8.56 ± 2.47) in the observation group were all better than those in the control group (P <0.05). The quality of life score of the observation group was better than that of the control group, and the difference was statistically significant (P <0.05). Conclusion: The treatment of acute tracheo-bronchitis with azithromycin combined with carbocisteine can effectively relieve the disease, with less side effects and high safety. It can be widely used clinically.